Dr Chi, MD, Discusses Phase 3 MAGNITUDE, SPARTAN, and TITAN Study Results

from Oncology Learning Network · host HMP Global

Kim Chi, MD, Vancouver Prostate Centre, Discusses Phase 3 MAGNITUDE study of niraparib as well as the SPARTAN and TITAN studies, presented at 2022 ASCO GU Meeting.

Episode metadata supplied by the publisher feed · Published Feb 17, 2022

Embed this episode

Attribution link and audio player

Ready to play

Dr Chi, MD, Discusses Phase 3 MAGNITUDE, SPARTAN, and TITAN Study Results

0:00 3:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Learning Network?

This episode is 3 minutes long.

When was this Oncology Learning Network episode published?

This episode was published on February 17, 2022.

Can I download this Oncology Learning Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!